UK Products

This page is intended for members of the public.

Medical Information can be contacted at medinfo@daiichi-sankyo.co.uk or on 0800 028 5122.

To report an adverse event experienced whilst taking a Daiichi Sankyo product, please report the event to:

Tel: 0800 028 5122
Email:  pharmacovigilance@daiichi-sankyo.co.uk

Information on the reporting of adverse events can be obtained from https://yellowcard.mhra.gov.uk/

Medicine displayed with black triangle symbol ▼: This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See  https://yellowcard.mhra.gov.uk/ for how to report side effects.

 

Products

ProductSummary of Product
Characteristics (SmPC)
Patient Information
Leaflet (PIL)
Efient
(prasugrel hydrochloride)

Great Britain SmPC

Northern Ireland SmPC

Great Britain PIL

Northern Ireland PIL

Enhertu▼
(trastuzumab deruxtecan)

Great Britain SmPC

Northern Ireland SmPC

Great Britain PIL

Northern Ireland PIL

Lixiana
(edoxaban tosilate)

Great Britain SmPC

Northern Ireland SmPC

Great Britain PIL

Northern Ireland PIL

Motifene
(diclofenic sodium)
UK SmPCUK PIL
Nilemdo▼
(bempedoic acid)

Great Britain SmPC

Northern Ireland SmPC

Great Britain PIL

Northern Ireland PIL

Nustendi▼
(bempedoic acid, ezetimibe)

Great Britain SmPC

Northern Ireland SmPC

Great Britain PIL

Northern Ireland PIL

Olmetec
(olmesartan medoximil)
UK SmPCUK PIL
Olmetec Plus 20 mg/12.5 mg
& 20 mg/12.5 mg
(olmesartan medoximil, hydrochlorothiazide)
UK SmPCUK PIL
Olmetec Plus 40 mg/12.5 mg
olmesartan medoximil, hydrochlorothiazide)
UK SmPCUK PIL
Sevikar
(olmesartan medoximil, amplodipine besilate)
UK SmPCUK PIL
Sevikar HCT
(olmesartan medoximil, amplodipine besilate, hydrochlorothiazide)
UK SmPCUK PIL

 

DSC/22/0038 March 2022

back to top